Summary
PerkinElmer Inc (PerkinElmer) is a provider of detection, imaging, and informatics solutions and services to diagnostics, research, laboratory services, environmental, and industrial markets. The company’s product portfolio comprises lab products and services; imaging components; diagnostic services for clinicians and families; and cord blood and tissue banking services. It also offers technologies for detection and identification of disease, contaminants, and biological pathways; imaging technologies for recording biological, cellular, and treatment events; and software platforms and informatics for data management, visualization, analytics, efficient workflow. PerkinElmer’s products find applications in early detection of genetic disorders, infectious disease testing, diagnosis of metabolic disorders, cancer treatment, drug discovery and other research activities. Its service offerings include analytics, compliance, contract research, custom research, genetic screening, instrumentation, prenatal screening, information, and scientific services. PerkinElmer is headquartered in Waltham, Massachusetts, US.
PerkinElmer Inc (PKI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
PerkinElmer Inc, Medical Devices Deals, 2011 to YTD 2017 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Albany Molecular Research Enters into Agreement with PerkinElmer 14
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 15
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 16
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 17
PerkinElmer Enters Into Agreement With National Center for Drug Screening 18
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 19
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 20
DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 21
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 21
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 22
Caliper Discovery Alliances & Services Enters Into Research Collaboration With Catholic Health Initiatives 23
Ingenuity Systems Expands Collaboration With Integromics 24
Caliper Life Sciences Enters Into Distribution Agreement With Trinean 25
NuGEN Technologies Enters Into Co-Marketing Agreement With Caliper Life Sciences 25
Licensing Agreements 26
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 26
Tissue Regeneration Enters Into Licensing Agreement With PerkinElmer 27
AuxoCell Labs Enters Into Licensing Agreement With ViaCord 28
IntegenX Enters Into Licensing Agreement With Caliper Life Sciences 29
Geospiza Enters Into Licensing Agreement With PerkinElmer 29
Debt Offering 30
PerkinElmer Completes Private Placement Of 5% Senior Notes Due 2021 For US$500 Million 30
Acquisition 31
PerkinElmer Acquires Ceiba Solutions 31
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 32
PerkinElmer Completes Acquisition Of Caliper Life Sciences For US$600 Million 33
PerkinElmer Acquires Labtronics 35
PerkinElmer Completes Acquisition Of CambridgeSoft 36
PerkinElmer Acquires ArtusLabs 37
PerkinElmer Acquires Chemagen Biopolymer 38
PerkinElmer Inc - Key Competitors 40
Key Employees 41
Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 48
Strategy And Business Planning 48
Sep 26, 2016: PerkinElmer Announces New Organizational Structure 48
Financial Announcements 49
May 04, 2017: PerkinElmer Announces Financial Results for the First Quarter of 2017 49
Feb 02, 2017: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2016 50
Nov 07, 2016: PerkinElmer Announces Financial Results for the Third Quarter of 2016 52
Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 53
May 05, 2016: PerkinElmer Announces Financial Results for the First Quarter of 2016 54
Feb 04, 2016: PerkinElmer Announces Financial Results for Fourth Quarter and Full Year 2015 55
Corporate Communications 57
Oct 17, 2016: PerkinElmer Elects Samuel Chapin to Board of Directors 57
Product News 58
Oct 10, 2016: PerkinElmer’s New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs 58
Oct 10, 2016: PerkinElmer's New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs 60
May 04, 2016: PerkinElmer and Covaris offer next gen sequencing grade nucleic acid purification and automated sample prep from FFPE tissue samples 62
Mar 23, 2017: PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting 63
Jan 25, 2016: PerkinElmer Launches New Solutions to Improve Speed and Effectiveness of Life Sciences Research Processes 65
Jan 23, 2017: PerkinElmer’s NexION 2000 ICP-MS Provides Industry-Leading Versatility for Trace Elemental Analyses 66
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67
List of Tables
PerkinElmer Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
PerkinElmer Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
PerkinElmer Inc, Deals By Therapy Area, 2011 to YTD 2017 9
PerkinElmer Inc, Medical Devices Deals, 2011 to YTD 2017 10
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
PerkinElmer Forms Joint Venture with Genome Institute of Singapore 13
Albany Molecular Research Enters into Agreement with PerkinElmer 14
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 15
ViaCord Enters Into Agreement With Center for International Blood and Marrow Transplant Research For Stem Cell Therapy Research 16
TrovaGene Enters Into R&D Agreement With PerkinElmer Health Sciences 17
PerkinElmer Enters Into Agreement With National Center for Drug Screening 18
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 19
Integromics Enters Into Co-Development Agreement With Galician Foundation Of Genomic Medicine 20
DxTerity Diagnostics Enters Into Technology Integration Agreement With Caliper Life Sciences 21
PerkinElmer Enters Into Distribution Agreement With Rubicon Genomics 21
Roche NimbleGen Enters Into Co-Marketing Agreement With Caliper Life Sciences 22
Caliper Discovery Alliances & Services Enters Into Research Collaboration With Catholic Health Initiatives 23
Ingenuity Systems Expands Collaboration With Integromics 24
Caliper Life Sciences Enters Into Distribution Agreement With Trinean 25
NuGEN Technologies Enters Into Co-Marketing Agreement With Caliper Life Sciences 25
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 26
Tissue Regeneration Enters Into Licensing Agreement With PerkinElmer 27
AuxoCell Labs Enters Into Licensing Agreement With ViaCord 28
IntegenX Enters Into Licensing Agreement With Caliper Life Sciences 29
Geospiza Enters Into Licensing Agreement With PerkinElmer 29
PerkinElmer Completes Private Placement Of 5% Senior Notes Due 2021 For US$500 Million 30
PerkinElmer Acquires Ceiba Solutions 31
PerkinElmer Acquires Shanghai Haoyuan Biotech From Medigen Biotech For US$38 Million 32
PerkinElmer Completes Acquisition Of Caliper Life Sciences For US$600 Million 33
PerkinElmer Acquires Labtronics 35
PerkinElmer Completes Acquisition Of CambridgeSoft 36
PerkinElmer Acquires ArtusLabs 37
PerkinElmer Acquires Chemagen Biopolymer 38
PerkinElmer Inc, Key Competitors 40
PerkinElmer Inc, Key Employees 41
PerkinElmer Inc, Other Locations 42
PerkinElmer Inc, Subsidiaries 43List of Figures
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
PerkinElmer Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
PerkinElmer Inc, Medical Devices Deals, 2011 to YTD 2017 10
